HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of oral leukoplakia with carbon dioxide and potassium-titanyl-phosphate lasers: a comparison.

AbstractPURPOSE:
To determine whether the treatment of oral leukoplakia with potassium-titanyl-phosphate (KTP) lasers versus CO(2) lasers results in lower recurrence rates.
MATERIALS AND METHODS:
Retrospective data were collected from the records of 30 patients (mean age 75.6 years) with 35 primary oral leukoplakia who had their lesions ablated by KTP laser, and 45 patients (mean age 59.9 years) with 59 primary oral leukoplakia who had CO(2) laser treatment. The recurrence rates of lesions between these 2 groups was then compared.
RESULTS:
A statistically significant (P = .049) reduction in recurrence rates for those patients treated with KTP lasers versus CO(2) lasers was found.
CONCLUSION:
The use of KTP lasers for the treatment of oral leukoplakia may result in lower recurrence rates than when using CO(2) lasers.
AuthorsBernard Lim, Andrew Smith, Arun Chandu
JournalJournal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons (J Oral Maxillofac Surg) Vol. 68 Issue 3 Pg. 597-601 (Mar 2010) ISSN: 1531-5053 [Electronic] United States
PMID20171477 (Publication Type: Comparative Study, Journal Article)
CopyrightCrown Copyright (c) 2010. Published by Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Disease-Free Survival
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Lasers, Gas (therapeutic use)
  • Lasers, Solid-State (therapeutic use)
  • Leukoplakia, Oral (surgery)
  • Male
  • Middle Aged
  • Mouth Neoplasms (surgery)
  • Neoplasm Recurrence, Local
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: